March 25, 2016, IBA -- IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces today that it has signed a contract with the University Hospitals Leuven (UZ Leuven) and Katholieke Universiteit Leuven (KU Leuven) to install Belgium’s first proton therapy center in a project with Université Catholique de Louvain (UCL), Cliniques universitaires Saint-Luc and other Belgian universities.

IBA was awarded the contract following a comprehensive European public tender conducted by UZ Leuven. IBA will equip the new center with its Proteus®ONE* system. The contract will also include a long-term maintenance agreement. The typical end-user price for a Proteus®ONE system with such a maintenance contract is between EUR 35 and 40 million. This new center is expected to open in 2018.

Olivier Legrain, Chief Executive Officer of IBA commented: “We are excited to have been selected to install Belgium’s first proton therapy center, bringing access to the most advanced radiation therapy technology to Belgian cancer patients. We are proud to install our cutting edge Proteus®ONE system so close to our headquarters and we look forward to collaborating with leading institutions like UZ Leuven, KU Leuven, UCL, Saint-Luc, and the other Belgian universities involved in the project.”
Marc Decramer, Chief Executive Officer of UZ Leuven commented: “We are very pleased to announce that we will be working with IBA. The UZ Leuven mission is to deliver the highest quality and most innovative patient care with unrelenting attention to clinical excellence, patient care and patient safety. It was therefore a natural decision for us to equip our hospital with a proton therapy solution as it is the most targeted treatment in the fight against cancer. Following a comprehensive public tender, we have chosen IBA because it provided the proton therapy solution that best fitted our needs.”

Hospital Installs Homepage